NunnA, ZallerN, DickmanS, TrimburC, NijhawanA and RichJ D. 2009. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend., 105: 83–88.
2.
ChandlerR K, FletcherB W and VolkowN D. 2009. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA., 301: 183–190.
3.
MaguraS, RosenblumA and JosephH. 1992. Evaluation of in-jail methadone maintenance: preliminary results. NIDA Res Monogr., 118: 192–210.
4.
KinlockT W, GordonM S, SchwartzR P, FitzgeraldT T and O'GradyK E. 2009. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat., 37: 277–285.
5.
MaguraS, LeeJ D, HershbergerJ, JosephH, MarschL, ShropshireC and RosenblumA. 2009. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend., 99: 222–230.
6.
LeeJ D, GrossmanE, DiRoccoD and GourevitchM N. 2009. Home buprenorphine/naloxone induction in primary care. J Gen Intern Med., 24: 226–232.
7.
WangE A, MooreB A, SullivanL E and FiellinD A. 2010. Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone. J Gen Intern Med., 25: 670–674.
8.
KrupitskyE, NunesE V, LingW, IlleperumaA, GastfriendD R and SilvermanB L. 2011. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet., 377: 1506–1513.
9.
DoleV P, NyswanderM E and WarnerA. 1968. Successful treatment of 750 criminal addicts. JAMA., 206: 2708–2711.
10.
DoleV P, RobinsonJ W, OrracaJ, TownsE, SearcyP and CaineE. 1969. Methadone treatment of randomly selected criminal addicts. N Engl J Med., 280: 1372–1375.
11.
DoleV P. 1972. Detoxification of sick addicts in prison. JAMA., 220: 366–369.
